65,437 trials
Allografts · Rejection; Transplant, Kidney · Transplant Rejection
Primary: Percentage of Participants With Treated Biopsy-proven Acute Rejection (tBPAR) of Grade 1A or Higher, Graft Loss or Death at Week 24 — 25.0 percentage of participants
Aging
Primary: Change of Fine Lines and Wrinkles — 1.25; 1.625; 1; 1.56 score on a scale
Uncontrolled Gout
Primary: Percentage of Serum Uric Acid (sUA) Responders (sUA < 6 mg/dL) During Month 6 — 9.1 percentage of participants
Arthritis of Hip
Primary: Averaged Pain Score — 3.75; 4.11 score on a scale
Neoplasms
Primary: Maximum Observed Concentration (Cmax) of Talazoparib Following Single Oral Dose — 8.506 nanogram/milliliter (ng/mL)
Healthy
Primary: Part A, B and C: Area Under the Plasma Concentration-Time Curve From Time Zero to the Last Quantifiable Concentration (AUC 0-t) of Tepotinib — 16146; 18645; 12609; 23457…
Cardiovascular Diseases
Primary: #HerHEART Risk Score in AYA From Baseline — 0.10; 0.08 Percentage Risk
Sleep Apnea, Obstructive · Pulmonary Disease, Chronic Obstructive · Respiration Disorders
Primary: OSA Cohort: Apnea-Hypopnea Index (AHI) on Day 8 of Treatment Periods 1 and 2 — 45.09; 44.90 events (apnea plus hyponea) per hour
Aphakia · Presbyopia
Primary: Percentage of Eyes With Best Corrected Distance Visual Acuity (BCDVA) Equal to or Better Than 0.3 LogMAR - Monocular — 100; 98.5; 99.3 percentage of eyes
Influenza, Human
Primary: Percentage of Seroprotected Participants for Anti-hemagglutination Inhibition (HI) Antibodies Against Vaccine-homologous H7N9 — 27.1; 27.7; 23.5; 26.5 Percentage of…
Cancer
Primary: 1a. Dietary Intake: ASA24 (Fiber) — 18.45; 18.17; 15.89; 20.73 grams/day — p=.255
Postoperative Pain · Obstetric Pain · Opioid Use
Primary: Visual Analog Pain Score — 3.5; 4.1; 5.2; 5.2 score on a scale — p=0.3
Lung Cancer · Neoplasms, Lung · Neoplasms, Pulmonary
Primary: Feasibility of Self-reporting Symptoms Using Moovcare® — 66.0 percentage of e-PRO surveys completed
Diabetes Mellitus, Type 1
Primary: Distribution of Participants Responses as Regards DSMQ Glucose Management Domain — 13; 56; 39; 45 Participants
Recurrent Plasma Cell Myeloma · Refractory Plasma Cell Myeloma
Primary: MTD, Defined as the Highest Dose in Which =< 1/6 Patients Experience a Dose-limiting Toxicity, Graded According to the National Cancer Institute Common Terminology…